Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis

This is the first study of oral tofacitinib in adults with active ankylosing spondylitis. It is designed to obtain information on the efficacy and safety of 3 different doses of tofacitinib.


September 10, 2013
Rheumatology - Ankylosing Spondylitis
Philip J. Mease, MD

Inclusion Criteria:

  • Documented diagnosis of Ankylosing Spondylitis
  • Has active disease despite concurrent nonsteroidal anti-inflammatory drugs (NSAIDs) treatment or is intolerant to NSAIDs

Exclusion Criteria:

  • Pregnant or lactating females
  • Currently receiving or previous use of a Tumor Necrosis Factor (TNF) inhibitor or any biological agent
Allison Everett
206-386-3201
206-386-6248